235 related articles for article (PubMed ID: 10515418)
1. Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis.
Iyonaga K; Suga M; Yamamoto T; Ichiyasu H; Miyakawa H; Ando M
Eur Respir J; 1999 Aug; 14(2):383-9. PubMed ID: 10515418
[TBL] [Abstract][Full Text] [Related]
2. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression.
Bonfield TL; John N; Malur A; Barna BP; Culver DA; Kavuru MS; Thomassen MJ
Clin Immunol; 2005 Jan; 114(1):79-85. PubMed ID: 15596412
[TBL] [Abstract][Full Text] [Related]
3. Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production.
Meloni F; Alberti A; Bulgheroni A; Lupi A; Paschetto E; Marone Bianco A; Rodi G; Fietta A; Luisetti M; Baritussio A
Eur Respir J; 2002 Jun; 19(6):1128-35. PubMed ID: 12108868
[TBL] [Abstract][Full Text] [Related]
4. MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis.
Boitelle A; Gosset P; Copin MC; Vanhee D; Marquette CH; Wallaert B; Gosselin B; Tonnel AB
Eur Respir J; 1997 Mar; 10(3):557-62. PubMed ID: 9072984
[TBL] [Abstract][Full Text] [Related]
5. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
[TBL] [Abstract][Full Text] [Related]
6. [A case of pulmonary alveolar proteinosis accompanied with the elevation of CEA (carcinoembryonic antigen) in bronchoalveolar lavage fluid].
Tanaka F; Nakamura M; Nakashima H; Suga M; Sugimoto M; Ando M; Araki S; Higuchi S
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Aug; 27(8):968-73. PubMed ID: 2615113
[TBL] [Abstract][Full Text] [Related]
7. [Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia].
Suga M; Iyonaga K; Ando M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():175-80. PubMed ID: 9216211
[TBL] [Abstract][Full Text] [Related]
8. Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis.
Thomassen MJ; Raychaudhuri B; Bonfield TL; Malur A; Abraham S; Barna BP; Kavuru MS
Autoimmunity; 2003 Aug; 36(5):285-90. PubMed ID: 14567558
[TBL] [Abstract][Full Text] [Related]
9. SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.
Douda DN; Farmakovski N; Dell S; Grasemann H; Palaniyar N
Orphanet J Rare Dis; 2009 Dec; 4():29. PubMed ID: 20030831
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Alveolar Proteinosis Syndrome.
Suzuki T; Trapnell BC
Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
[TBL] [Abstract][Full Text] [Related]
11. Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis.
Hirakata Y; Kobayashi J; Sugama Y; Kitamura S
Eur Respir J; 1995 May; 8(5):689-96. PubMed ID: 7656937
[TBL] [Abstract][Full Text] [Related]
12. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
Huizar I; Kavuru MS
Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
[TBL] [Abstract][Full Text] [Related]
13. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.
Honda Y; Takahashi H; Shijubo N; Kuroki Y; Akino T
Chest; 1993 Feb; 103(2):496-9. PubMed ID: 8432143
[TBL] [Abstract][Full Text] [Related]
14. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.
Alam R; York J; Boyars M; Stafford S; Grant JA; Lee J; Forsythe P; Sim T; Ida N
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1398-404. PubMed ID: 8616572
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis.
Jahnz-Rózyk KM; Kuna P; Pirozyńska E
J Investig Allergol Clin Immunol; 1997; 7(4):254-9. PubMed ID: 9330191
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chen YC; Chang SC
Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
[TBL] [Abstract][Full Text] [Related]
19. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis.
Bonella F; Long X; He X; Ohshimo S; Griese M; Guzman J; Costabel U
Respirology; 2017 Oct; 22(7):1371-1378. PubMed ID: 28569052
[TBL] [Abstract][Full Text] [Related]
20. The lavage fluid from a patient with alveolar proteinosis inhibits the in vitro chemiluminescence response and arachidonic acid metabolism of normal guinea pig alveolar macrophages.
Carre PC; Didier AP; Pipy BR; Forgue MF; Beraud MF; Meeus EP; Caratero AL; Leophonte PJ
Am Rev Respir Dis; 1990 Nov; 142(5):1068-72. PubMed ID: 2122784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
